Condition
Pancreatic Adenocarcinoma Advanced or Metastatic clinical trials and research
Research outlook What's coming for Pancreatic cancer: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 2 Pancreatic Adenocarcinoma Advanced or Metastatic clinical trials that are recruiting, at sites in 2 countries (most in Italy (1), China (1)). By phase: Phase 3 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
INV-8989 in KRAS G12D-mutant advanced solid tumors
This study tests INV-8989 to see if it can be safely given and potentially help patients with KRAS G12D-mutant advanced solid tumors.
-
Comparing two chemotherapy approaches for advanced pancreatic cancer
This study is testing whether switching to a different chemotherapy combination or continuing the current treatment helps people with advanced pancreatic cancer live longer and feel better.
Related topics
Quick answers
How many Pancreatic Adenocarcinoma Advanced or Metastatic clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Italy (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.